Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hiroaki Kataoka

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Venues

Cancer science

International journal of molecular sciences

BMC research notes

Pathology international

University of Miyazaki

Faculty of Medicine, University of Miyazaki (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Miyazaki

Japan

Professor :: Department of Pathology

Education History

Faculty of Medicine, University of Miyazaki

Japan

PHD :: Department of Pathology

Publications

Makiko Kawaguchi, Hiroaki Kataoka, Takumi Kiwaki, Weiting Liang, Sayaka Nagata, Kazuo Kitamura, Tsuyoshi Fukushima
Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin-4 expression in the colonic epithelium. FEBS open bio (2023)
Makiko Kawaguchi, Hiroaki Kataoka, Takumi Kiwaki, Liang Weiting, Sayaka Nagata, Kazuo Kitamura, Tsuyoshi Fukushima
Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin-4 expression in the colonic epithelium. FEBS open bio (2023)
Roman Szabo, Makiko Kawaguchi, Hiroaki Kataoka, Thomas H Bugge
Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM. Development (Cambridge, England) (2023)
Fumiki Yamashita, Takashi Kaieda, Takeshi Shimomura, Makiko Kawaguchi, Chen-Yong Lin, Michael D Johnson, Hiroyuki Tanaka, Takumi Kiwaki, Tsuyoshi Fukushima, Hiroaki Kataoka
Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1. The FEBS journal 289 (12) (2022)
Takumi Kiwaki, Hiroaki Kataoka
Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine. Journal of personalized medicine 12 (5) (2022)
Aya Izumi, Koji Yamamoto, Makiko Kawaguchi, Fumiki Yamashita, Tsuyoshi Fukushima, Takumi Kiwaki, Hiroyuki Tanaka, Yoshihiro Yamashita, Hiroaki Kataoka
Insufficiency of hepatocyte growth factor activator inhibitor-1 confers lymphatic invasion of tongue carcinoma cells. Cancer science 113 (6) (2022)
Kosho Iwao, Kunihiko Umekita, Masatoshi Kimura, Chihiro Iwao, Mao Rikitake, Ayako Aizawa, Yumi Kariya, Motohiro Matsuda, Syunichi Miyauchi, Ichiro Takajo, Takumi Kiwaki, Tsuyoshi Fukushima, Hiroaki Kataoka, Tadaki Suzuki, Akihiko Okayama, Kunihiko Umekita
Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case. Viruses 13 (6) (2021)
Bethasiwi P, Radha Madhyastha, Harishkumar Madhyastha, Queen Intan Nurrahmah, Masugi Maruyama, Nakajima Y, Hiroaki Kataoka, Nozomi Watanabe
Retinoic acid attenuates nuclear factor kappaB mediated induction of NLRP3 inflammasome. Pharmacological reports : PR (2021)
Hidemi Hattori, Yuma Hanai, Yuto Oshima, Hiroaki Kataoka, Nozomu Eto
Excessive Intake of High-Fructose Corn Syrup Drinks Induces Impaired Glucose Tolerance. Biomedicines 9 (5) (2021)
Takumi Kiwaki, Mayumi Akaki Nagayasu, Naoshi Yamada, Yuki Kodama, Yoshiko Umekita, Tsuyoshi Fukushima, Hiroaki Kataoka, Hiroyuki Tanaka
Congenital tracheo-esophageal transition: A previously undescribed tracheo-esophageal malformation that showed direct transition of the trachea to the esophagus. Pathology international 72 (2) (2021)
Makiko Kawaguchi, Koji Yamamoto, Hiroaki Kataoka, Aya Izumi, Fumiki Yamashita, Takumi Kiwaki, Takahiro Nishida, Eric Camerer, Tsuyoshi Fukushima
Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in ApcMin/+ mice. Cancer science 111 (4) (2020)
Deokcheol Lee, Noboru Taniguchi, Katsuaki Sato, Narantsog Choijookhuu, Yoshitaka Hishikawa, Hiroaki Kataoka, Hidetaka Morinaga, Martin Lotz, Etsuo Chosa
Author Correction: HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles. Scientific reports 10 (1) (2020)
Shoichiro Mukai, Koji Yamasaki, Masato Fujii, Takahiro Nagai, Naoki Terada, Hiroaki Kataoka, Toshiyuki Kamoto
Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers. International journal of molecular sciences 21 (8) (2020)
Kenji Yorita, Akinobu Ohno, Takahiro Nishida, Kazuhiro Kondo, Toshihiko Ohtomo, Hiroaki Kataoka
Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas. BMC research notes 12 (1) (2019)
Makiko Kawaguchi, Koji Yamamoto, Naoki Takeda, Tsuyoshi Fukushima, Fumiki Yamashita, Katsuaki Sato, Kenichiro Kitamura, Yoshitaka Hippo, James W Janetka, Hiroaki Kataoka
Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine. Communications biology 2 (2019)
Takahiro Nishida, Hiroaki Kataoka
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma. Cancers 11 (9) (2019)
Tsuyoshi Fukushima, Makiko Kawaguchi, Koji Yamamoto, Fumiki Yamashita, Aya Izumi, Takashi Kaieda, Yuka Takezaki, Hiroshi Itoh, Hideo Takeshima, Hiroaki Kataoka
Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas. Cancer science 109 (9) (2018)
Tsuyoshi Fukushima, Shuichiro Uchiyama, Hiroyuki Tanaka, Hiroaki Kataoka
Hepatocyte Growth Factor Activator: A Proteinase Linking Tissue Injury with Repair. International journal of molecular sciences 19 (11) (2018)
Hiroaki Kataoka, Makiko Kawaguchi, Tsuyoshi Fukushima, Takeshi Shimomura
Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer. Pathology international 68 (3) (2018)
Deokcheol Lee, Noboru Taniguchi, Katsuaki Sato, Narantsog Choijookhuu, Yoshitaka Hishikawa, Hiroaki Kataoka, Hidetaka Morinaga, Martin Lotz, Etsuo Chosa
HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles. Scientific reports 8 (1) (2018)
Koji Yamasaki, Shoichiro Mukai, Satoru Sugie, Takahiro Nagai, Kozue Nakahara, Toyoharu Kamibeppu, Hiromasa Sakamoto, Noboru Shibasaki, Naoki Terada, Yoshinobu Toda, Hiroaki Kataoka, Toshiyuki Kamoto
Dysregulated HAI-2 Plays an Important Role in Renal Cell Carcinoma Bone Metastasis through Ligand-Dependent MET Phosphorylation. Cancers 10 (6) (2018)
Koji Yamasaki, Shoichiro Mukai, Takahiro Nagai, Kozue Nakahara, Masato Fujii, Naoki Terada, Akinobu Ohno, Yuichiro Sato, Yoshinobu Toda, Hiroaki Kataoka, Toshiyuki Kamoto
Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis. International journal of molecular sciences 19 (12) (2018)
Chihiro Sakugawa, Yukihiro Haruyama, Hiroyuki Tanaka, Tsuyoshi Fukushima, Makiko Kawaguchi, Hiroaki Kataoka
Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma. BMC research notes 10 (1) (2017)

Hiroaki Kataoka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroaki Kataoka